International epidemiology of antimicrobial resistance in people living with chronic lung infection
Global tracking of antibiotic resistance in chronic lung infections reveals patterns that can guide better treatment choices and stewardship strategies.
Published in Thorax, this international multicenter study characterizes the epidemiology of antimicrobial resistance in people with chronic lung infections due to bronchiectasis and cystic fibrosis across multiple countries. The findings expose a major and growing global threat in rare pulmonary disease management with direct implications for antibiotic stewardship and therapy selection.
What the study was
- Study design
- International multicenter observational study
- Population
- International cohort of patients with bronchiectasis and cystic fibrosis with chronic lung infections
- Category
- Public Health
- Maturity
- Validated
- Journal
- Thorax
Why it surfaced
Thorax international study on AMR in rare chronic lung diseases (bronchiectasis/CF); large multicenter dataset, high unmet need, actionable AMR surveillance data for treatment guidance.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.